Induction of intestinal pro-inflammatory immune responses by lipoteichoic acid

Journal of Inflammation

Volumn 9, Issue , 2012, Pages

  Zadeh, Mojgan ^a   Khan, Mohammad W ^b   Goh, Yong Jun ^c   Selle, Kurt ^c   Owen, Jennifer L ^a   Klaenhammer, Todd ^c   Mohamadzadeh, Mansour ^a  

^a UNIVERSITY OF FLORIDA   (United States)

^b NORTHWESTERN UNIVERSITY   (United States)

^c NORTH CAROLINA STATE UNIVERSITY   (United States)

Author keywords

Dendritic cells; Dextran sulfate sodium; Inflammatory bowel disease; Lipoteichoic acid; Toll like receptor 2

Indexed keywords

BACTERIAL PROTEIN; LIPOTEICHOIC ACID; SURFACE LAYER PROTEIN A; SURFACE LAYER PROTEIN B; SURFACE LAYER PROTEIN X; UNCLASSIFIED DRUG;

ANIMAL EXPERIMENT; ANIMAL MODEL; ARTICLE; BACTERIAL STRAIN; CELLULAR IMMUNITY; COLITIS; CONTROLLED STUDY; DENDRITIC CELL; DISEASE SEVERITY; GENE; GENE DELETION; GENE EXPRESSION REGULATION; GENE PRODUCT; GENETIC CODE; IMMUNOSTIMULATION; IN VIVO STUDY; INNATE IMMUNITY; INTESTINE FLORA; INTRACELLULAR SIGNALING; LACTOBACILLUS ACIDOPHILUS; MACROPHAGE ACTIVATION; MOLECULAR DYNAMICS; MOUSE; NONHUMAN; PROTEIN EXPRESSION; STAPHYLOCOCCUS AUREUS; SURFACE LATER PROTEIN A GENE; SURFACE LATER PROTEIN B GENE; SURFACE LATER PROTEIN X GENE; T LYMPHOCYTE ACTIVATION; TISSUE INJURY; WILD TYPE;

BACTERIA (MICROORGANISMS); LACTOBACILLUS ACIDOPHILUS; MUS; POSIBACTERIA; STAPHYLOCOCCUS AUREUS;

EID: 84863418169     PISSN: None     EISSN: 14769255     Source Type: Journal    
DOI: 10.1186/1476-9255-9-7     Document Type: Article

References (59)

1. Oral tolerance. Weiner HL, da Cunha AP, Quintana F, Wu H, Immunol Rev 2011 241 1 241 259 10.1111/j.1600-065X.2011.01017.x 21488901
2. Has the microbiota played a critical role in the evolution of the adaptive immune system? Lee YK, Mazmanian SK, Science 2010 330 1768 1773 10.1126/science.1195568 21205662
3. The fundamental basis of inflammatory bowel disease. Strober W, Fuss I, Mannon P, J Clin Invest 2007 117 514 521 10.1172/JCI30587 17332878 (Pubitemid 46348505)
4. T cells in inflammatory bowel disease: protective and pathogenic roles. Powrie F, Immunity 1995 3 171 174 10.1016/1074-7613(95)90086-1 7648390
5. In IBD eight can come before four. Cheroutre H, Gastroenterology 2006 131 667 670 10.1053/j.gastro.2006.06.041 16890619 (Pubitemid 44142479)
6. Experimental models of inflammatory bowel disease reveal innate, adaptive, and regulatory mechanisms of host dialogue with the microbiota. Elson CO, Cong Y, McCracken VJ, Dimmitt RA, Lorenz RG, Weaver CT, Immunol Rev 2005 206 260 276 10.1111/j.0105-2896.2005.00291.x 16048554 (Pubitemid 41105175)
7. Regulatory T cells and intestinal homeostasis. Coombes JL, Robinson NJ, Maloy KJ, Uhlig HH, Powrie F, Immunol Rev 2005 204 184 194 10.1111/j.0105-2896. 2005.00250.x 15790359 (Pubitemid 40460502)
8. Cytotoxic T lymphocyte-associated antigen 4 plays an essential role in the function of CD25(+)CD4(+) regulatory cells that control intestinal inflammation. Read S, Malmstrom V, Powrie F, J Exp Med 2000 192 295 302 10.1084/jem.192.2.295 10899916 (Pubitemid 30470312)
9. Foxp3 programs the development and function of CD4 + CD25+ regulatory T cells. Fontenot JD, Gavin MA, Rudensky AY, Nat Immunol 2003 4 330 336 12612578 (Pubitemid 36432314)
10. Atypical lipoteichoic acids of gram-positive bacteria. Sutcliffe IC, Shaw N, J Bacteriol 1991 173 7065 7069 1938910
11. Excretion of lipoteichoic acid by group A streptococci. Influence of penicillin on excretion and loss of ability to adhere to human oral mucosal cells. Alkan ML, Beachey EH, J Clin Invest 1978 61 671 677 10.1172/JCI108979 346604
12. Location, synthesis and function of glycolipids and polyglycerolphosphate lipoteichoic acid in Gram-positive bacteria of the phylum Firmicutes. Reichmann NT, Grundling A, FEMS MicrobiolLett 2011 319 97 105 10.1111/j.1574-6968.2011. 02260.x
13. LTA and LPS mediated activation of protein kinases in the regulation of inflammatory cytokines expression in macrophages. Su SC, Hua KF, Lee H, Chao LK, Tan SK, Yang SF, et al. ClinChimActa 2006 374 106 115 (Pubitemid 44572245)
14. Intrinsic nitric oxide-stimulatory activity of lipoteichoic acids from different Gram-positive bacteria. Zidek Z, Farghali H, Kmonickova E, Nitric Oxide 2010 23 300 310 10.1016/j.niox.2010.09.001 20850558
15. Lipoteichoic acid-induced TNF-alpha and IL-6 gene expressions and oxidative stress production in macrophages are suppressed by ketamine through downregulating Toll-like receptor 2-mediated activation oF ERK1/2 and NFkappaB. Chang HC, Lin KH, Tai YT, Chen JT, Chen RM, Shock 2010 33 485 492 19823118
16. Mechanism of gram-positive shock: identification of peptidoglycan and lipoteichoic acid moieties essential in the induction of nitric oxide synthase, shock, and multiple organ failure. Kengatharan KM, De Kimpe S, Robson C, Foster SJ, Thiemermann C, J Exp Med 1998 188 305 315 10.1084/jem.188.2.305 9670043 (Pubitemid 28357759)
17. Pathogen recognition and innate immunity. Akira S, Uematsu S, Takeuchi O, Cell 2006 124 783 801 10.1016/j.cell.2006.02.015 16497588 (Pubitemid 43261452)
18. Regulation of induced colonic inflammation by Lactobacillus acidophilus deficient in lipoteichoic acid. Mohamadzadeh M, Pfeiler EA, Brown JB, Zadeh M, Gramarossa M, Managlia E, et al. Proc NatlAcadSci USA 2011 108 4623 4630 10.1073/pnas.1005066107
19. Lipoteichoic acid-deficient Lactobacillus acidophilus regulates downstream signals. Saber R, Zadeh M, Pakanati KC, Bere P, Klaenhammer T, Mohamadzadeh M, Immunotherapy 2011 3 337 347 10.2217/imt.10.119 21395377
20. Development and application of a upp-based counterselective gene replacement system for the study of the S-layer protein SlpX of Lactobacillus acidophilus NCFM. Goh YJ, Azcarate-Peril MA, O'Flaherty S, Durmaz E, Valence F, Jardin J, et al. Appl Environ Microbiol 2009 75 3093 3105 10.1128/AEM.02502-08 19304841
21. Efficient system for directed integration into the Lactobacillus acidophilus and Lactobacillus gasseri chromosomes via homologous recombination. Russell WM, Klaenhammer TR, Appl Environ Microbiol 2001 67 4361 4364 10.1128/AEM.67.9.4361-4364.2001 11526048 (Pubitemid 33641741)
22. Interleukin 15 skews monocyte differentiation into dendritic cells with features of Langerhans cells. Mohamadzadeh M, Berard F, Essert G, Chalouni C, Pulendran B, Davoust J, et al. J Exp Med 2001 194 1013 1020 10.1084/jem.194.7. 1013 11581322 (Pubitemid 32953269)
23. Efficient presentation of soluble antigen by cultured human dendritic cells is maintained by granulocyte/macrophage colony-stimulating factor plus interleukin 4 and downregulated by tumor necrosis factor alpha. Sallusto F, Lanzavecchia A, J Exp Med 1994 179 1109 1118 10.1084/jem.179.4.1109 8145033
24. Dendritic cells generated in the presence of GM-CSF plus IL-15 prime potent CD8+ Tc1 responses in vivo. Pulendran B, Dillon S, Joseph C, Curiel T, Banchereau J, Mohamadzadeh M, Eur J Immunol 2004 34 66 73 10.1002/eji.200324567 14971031 (Pubitemid 38111521)
25. Live imaging of cysteine-cathepsin activity reveals dynamics of focal inflammation, angiogenesis, and polyp growth. Gounaris E, Tung CH, Restaino C, Maehr R, Kohler R, Joyce JA, et al. PLoS One 2008 3 2916 10.1371/journal.pone. 0002916 18698347
26. Lactobacilli activate human dendritic cells that skew T cells toward T helper 1 polarization. Mohamadzadeh M, Olson S, Kalina WV, Ruthel G, Demmin GL, Warfield KL, et al. Proc NatlAcadSci USA 2005 02 8 2880 2885 (Pubitemid 40299885)
27. Recognition of commensal microflora by toll-like receptors is required for intestinal homeostasis. Rakoff-Nahoum S, Paglino J, Eslami-Varzaneh F, Edberg S, Medzhitov R, Cell 2004 118 229 241 10.1016/j.cell.2004.07.002 15260992 (Pubitemid 38962578)
28. Clinicopathologic study of dextran sulfate sodium experimental murine colitis. Cooper HS, Murthy SN, Shah RS, Sedergran DJ, Lab Invest 1993 69 238 249 8350599
29. Treatment of dextran sulfate sodium-induced murine colitis by intracoloniccyclosporin. Murthy SN, Cooper HS, Shim H, Shah RS, Ibrahim SA, Sedergran DJ, Dig Dis Sci 1993 38 1722 1734 10.1007/BF01303184 8359087 (Pubitemid 23271431)
30. Bacterial teichoic acids reverse predominant IL-12 production induced by certain lactobacillus strains into predominant IL-10 production via TLR2-dependent ERK activation in macrophages. Kaji R, Kiyoshima-Shibata J, Nagaoka M, Nanno M, Shida K, J Immunol 2010 184 3505 3513 10.4049/jimmunol. 0901569 20190136
31. Three-colour fluorescence immunohistochemistry reveals the diversity of cells staining for macrophage markers in murine spleen and liver. Lloyd CM, Phillips AR, Cooper GJ, Dunbar PR, J Immunol Methods 2008 334 70 81 10.1016/j.jim.2008.02.005 18367204
32. Cooperation of TLR2 with MyD88, PI3K, and Rac1 in lipoteichoic acid-induced cPLA2/COX-2-dependent airway inflammatory responses. Lee IT, Lee CW, Tung WH, Wang SW, Lin CC, Shu JC, et al. Am J Pathol 2010 176 1671 1684 10.2353/ajpath.2010.090714 20167866
33. Lipoteichoic acid induces HO-1 expression via the TLR2/MyD88/c-Src/NADPH oxidase pathway and Nrf2 in human tracheal smooth muscle cells. Lee IT, Wang SW, Lee CW, Chang CC, Lin CC, Luo SF, et al. J Immunol 2008 181 5098 5110 18802114
34. CD8 + CD28- regulatory T lymphocytes prevent experimental inflammatory bowel disease in mice. Menager-Marcq I, Pomie C, Romagnoli P, van Meerwijk JP, Gastroenterology 2006 131 1775 1785 10.1053/j.gastro.2006.09.008 17087950 (Pubitemid 44970462)
35. A CD8+/CD103high T cell subset regulates TNF-mediated chronic murine ileitis. Ho J, Kurtz CC, Naganuma M, Ernst PB, Cominelli F, Rivera-Nieves J, J Immunol 2008 180 2573 2580 18250468
36. Generation and function of immunosuppressive human and murine CD8(+) T cells by transforming growth factor-beta and retinoic acid. Fleissner D, Frede A, Knott M, Knuschke T, Geffers R, Hansen W, et al. Immunol 2011 134 82 92 10.1111/j.1365-2567.2011.03469.x
37. Expansion of CD8+ T cells with regulatory function after interaction with intestinal epithelial cells. Allez M, Brimnes J, Dotan I, Mayer L, Gastroenterology 2002 123 1516 1526 10.1053/gast.2002.36588 12404227 (Pubitemid 35231652)
38. Defects in CD8+ regulatory T cells in the lamina propria of patients with inflammatory bowel disease. Brimnes J, Allez M, Dotan I, Shao L, Nakazawa A, Mayer L, J Immunol 2005 174 5814 5822 15843585 (Pubitemid 40593226)
39. Immunity, inflammation, and allergy in the gut. Macdonald TT, Monteleone G, Science 2005 307 1920 1925 10.1126/science.1106442 15790845 (Pubitemid 40404695)
40. Biological therapies for inflammatory bowel diseases. Rutgeerts P, Vermeire S, Van Assche G, Gastroenterology 2009 136 1182 1197 10.1053/j.gastro.2009.02.001 19249397
41. The immunology of mucosal models of inflammation. Strober W, Fuss IJ, Blumberg RS, Annu Rev Immunol 2002 20 495 549 10.1146/annurev.immunol.20.100301. 064816 11861611 (Pubitemid 34293433)
42. T cell-mediated pathology in two models of experimental colitis depends predominantly on the interleukin 12/Signal transducer and activator of transcription (Stat)-4 pathway, but is not conditional on interferon gamma expression by T cells. Simpson SJ, Shah S, Comiskey M, de Jong YP, Wang B, Mizoguchi E, et al. J Exp Med 1998 187 1225 1234 10.1084/jem.187.8.1225 9547334 (Pubitemid 28189112)
43. Helicobacter hepaticus-induced colitis in interleukin-10-deficient mice: cytokine requirements for the induction and maintenance of intestinal inflammation. Kullberg MC, Rothfuchs AG, Jankovic D, Caspar P, Wynn TA, Gorelick PL, et al. Infect Immun 2001 69 4232 4241 10.1128/IAI.69.7.4232-4241.2001 11401959 (Pubitemid 32574418)
44. Characterization of IL-17A-producing cells in celiac disease mucosa. Monteleone I, Sarra M, Del Vecchio Blanco G, Paoluzi OA, Franze E, Fina D, et al. J Immunol 2010 184 2211 2218 10.4049/jimmunol.0901919 20061410
45. Role of IL-21 in inflammatory bowel disease. Pallone F, Fina D, Caruso R, Monteleone G, Expert Rev ClinImmunol 2010 6 537 541
46. Interleukin-21: a new mediator of inflammation in systemic lupus erythematosus. Sarra M, Monteleone G, J Biomed Biotechnol 2010 2010 294582 20652041
47. Interferon-gamma-expressing cells are a major source of interleukin-21 in inflammatory bowel diseases. Sarra M, Monteleone I, Stolfi C, Fantini MC, Sileri P, Sica G, et al. Inflamm Bowel Dis 2010 16 1332 1339 20186935
48. IL-23/IL-17 axis in IBD. Sarra M, Pallone F, Macdonald TT, Monteleone G, Inflamm Bowel Dis 2010 16 1808 1813 10.1002/ibd.21248 20222127
49. Blocking TNF-alpha in mice reduces colorectal carcinogenesis associated with chronic colitis. Popivanova BK, Kitamura K, Wu Y, Kondo T, Kagaya T, Kaneko S, et al. J Clin Invest 2008 118 560 570 18219394 (Pubitemid 351206546)
50. Cell wall fraction of Enterococcus hirae ameliorates TNF-alpha-induced barrier impairment in the human epithelial tight junction. Miyauchi E, Morita H, Okuda J, Sashihara T, Shimizu M, Tanabe S, LettApplMicrobiol 2008 46 469 476 (Pubitemid 351422513)
51. IL-17 and Th17 Cells. Korn T, Bettelli E, Oukka M, Kuchroo VK, Annu Rev Immunol 2009 27 485 517 10.1146/annurev.immunol.021908.132710 19132915
52. Enhancement of experimental allergic encephalomyelitis in mice by antibodies against IFN-gamma. Billiau A, Heremans H, Vandekerckhove F, Dijkmans R, Sobis H, Meulepas E, et al. J Immunol 1988 140 1506 1510 3126227
53. Cutting edge: IFN-gamma is a negative regulator of IL-23 in murine macrophages and experimental colitis. Sheikh SZ, Matsuoka K, Kobayashi T, Li F, Rubinas T, Plevy SE, J Immunol 2010 184 4069 4073 10.4049/jimmunol.0903600 20228197
54. High susceptibility to collagen-induced arthritis in mice lacking IFN-gamma receptors. Manoury-Schwartz B, Chiocchia G, Bessis N, Abehsira-Amar O, Batteux F, Muller S, et al. J Immunol 1997 158 5501 5506 9164973 (Pubitemid 127681259)
55. Role of T cells and gamma interferon during induction of hypersensitivity to lipopolysaccharide by toxic shock syndrome toxin 1 in mice. Dinges MM, Schlievert PM, Infect Immun 2001 69 1256 1264 10.1128/IAI.69.3.1256-1264.2001 11179286 (Pubitemid 32187568)
56. Interferon gamma-dependent intestinal pathology contributes to the lethality in bacterial superantigen-induced toxic shock syndrome. Tilahun AY, Holz M, Wu TT, David CS, Rajagopalan G, PLoS One 2011 6 16764 10.1371/journal.pone.0016764 21304813
57. S layer protein A of Lactobacillus acidophilus NCFM regulates immature dendritic cell and T cell functions. Konstantinov SR, Smidt H, de Vos WM, Bruijns SC, Singh SK, Valence F, et al. Proc NatlAcadSci USA 2008 105 19474 19479 10.1073/pnas.0810305105
58. Chronic experimental colitis induced by dextran sulphate sodium (DSS) is characterized by Th1 and Th2 cytokines. Dieleman LA, Palmen MJ, Akol H, Bloemena E, Pena AS, Meuwissen SG, et al. Clin Exp Immunol 1998 114 385 391 10.1046/j.1365-2249.1998.00728.x 9844047 (Pubitemid 28539597)
59. Chemically induced mouse models of intestinal inflammation. Wirtz S, Neufert C, Weigmann B, Neurath MF, Nat Protoc 2007 2 541 546 17406617 (Pubitemid 47040018)